Marksans Pharma Limited (BOM:524404)
India flag India · Delayed Price · Currency is INR
181.65
-6.25 (-3.33%)
At close: Feb 13, 2026

Marksans Pharma Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Market Capitalization
82,363100,81568,83631,90318,62720,445
Market Cap Growth
-21.91%46.46%115.77%71.27%-8.89%259.35%
Enterprise Value
79,26696,31563,54929,74616,05219,467
Last Close Price
181.65221.57150.7169.7144.8348.99
PE Ratio
22.8626.4921.9411.989.978.57
PS Ratio
2.943.843.161.721.251.49
PB Ratio
3.044.053.301.811.522.26
P/TBV Ratio
3.234.283.511.951.672.50
P/FCF Ratio
-298.76319.1417.3635.2015.47
P/OCF Ratio
-48.7829.8813.4418.7711.45
EV/Sales Ratio
2.833.672.921.611.081.42
EV/EBITDA Ratio
15.2719.2114.659.296.685.81
EV/EBIT Ratio
18.3921.6316.5410.347.506.30
EV/FCF Ratio
-285.42294.6316.1930.3314.73
Debt / Equity Ratio
0.120.130.120.070.090.04
Debt / EBITDA Ratio
0.640.610.530.360.430.12
Debt / FCF Ratio
-9.5411.320.672.090.30
Net Debt / Equity Ratio
-0.12-0.15-0.22-0.34-0.19-0.19
Net Debt / EBITDA Ratio
-0.68-0.77-1.05-1.85-0.98-0.52
Net Debt / FCF Ratio
--11.38-21.20-3.23-4.46-1.31
Asset Turnover
-0.890.890.971.041.29
Inventory Turnover
-1.641.952.071.761.87
Quick Ratio
-2.642.993.342.091.62
Current Ratio
-4.624.784.913.373.02
Return on Equity (ROE)
-16.73%16.35%17.76%17.55%30.69%
Return on Assets (ROA)
-9.40%9.86%9.39%9.33%18.13%
Return on Invested Capital (ROIC)
13.76%18.11%20.40%20.94%18.80%36.93%
Return on Capital Employed (ROCE)
-16.10%16.80%15.60%16.70%33.30%
Earnings Yield
4.37%3.77%4.56%8.35%10.03%11.67%
FCF Yield
-0.34%0.31%5.76%2.84%6.46%
Dividend Yield
0.45%0.36%0.40%0.72%0.56%0.51%
Payout Ratio
-7.14%7.22%3.82%5.67%1.72%
Buyback Yield / Dilution
-0.10%--9.09%-1.49%-0.00%
Total Shareholder Return
0.35%0.36%-8.69%-0.77%0.56%0.51%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.